Executive VP, Translational Sciences

Laura D. Heckman is our Executive Vice President of Translational Sciences. She has extensive experience in a range of neurological disorders, including neurodevelopmental, neurodegenerative, and neuropsychiatric, and in CNS therapeutics drug development. Prior to joining Leal, she led preclinical development for CNS therapeutics programs at Prevail Therapeutics and Spark Therapeutics, advancing multiple therapies into the clinic for neurodegenerative and neurodevelopmental disorders. She holds a B.A. in Biology from the University of Pennsylvania, a Ph.D. in Molecular and Human Genetics from Baylor College of Medicine, and completed her postdoctoral training at The Rockefeller University.